Zupanc, C.; Franko, A.; Ĺ trbac, D.; DodiÄŤ Fikfak, M.; KovaÄŤ, V.; DolĹľan, V.; GoriÄŤar, K.
Serum Calretinin as a Biomarker in Malignant Mesothelioma. J. Clin. Med. 2021, 10, 4875.
https://doi.org/10.3390/jcm10214875
AMA Style
Zupanc C, Franko A, Ĺ trbac D, DodiÄŤ Fikfak M, KovaÄŤ V, DolĹľan V, GoriÄŤar K.
Serum Calretinin as a Biomarker in Malignant Mesothelioma. Journal of Clinical Medicine. 2021; 10(21):4875.
https://doi.org/10.3390/jcm10214875
Chicago/Turabian Style
Zupanc, Cita, Alenka Franko, Danijela Ĺ trbac, Metoda DodiÄŤ Fikfak, Viljem KovaÄŤ, Vita DolĹľan, and Katja GoriÄŤar.
2021. "Serum Calretinin as a Biomarker in Malignant Mesothelioma" Journal of Clinical Medicine 10, no. 21: 4875.
https://doi.org/10.3390/jcm10214875
APA Style
Zupanc, C., Franko, A., Ĺ trbac, D., DodiÄŤ Fikfak, M., KovaÄŤ, V., DolĹľan, V., & GoriÄŤar, K.
(2021). Serum Calretinin as a Biomarker in Malignant Mesothelioma. Journal of Clinical Medicine, 10(21), 4875.
https://doi.org/10.3390/jcm10214875